Urinary Biomarker Study With Sulindac and Difluoromethylornithine

Clinical trial NCT01636128 · WITHDRAWN

Trial details

NCT number: NCT01636128
Sponsor: Cancer Prevention Pharmaceuticals, Inc.
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Focus of Study: Drug Response Biomarkers, Chemoprevention, Neoplasms

Start date: 2014-03-01
Primary completion: 2016-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.